INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
16/01/2026
Voltar para busca
Dado oficial do USPTO
HALIOSEEK
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: Estados Unidos
Snapshot rápido
HALIOSEEK
ST13
US500000079213961Classe
5, 9, 10, 42, 44
Pedido
79213961
Registro
5592381
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
39
Atualização mais recente
17/01/2026
Tipo de marca
Verbal
Classes Nice
5, 9, 10, 42, 44
Data de depósito
05/05/2017
Data de registro
30/10/2018
Data de expiração
-
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
16/05/2025
Última transação
17/01/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
709
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
34
Localização do titular
FR
Examinador
BROOKSHIRE,DAVID AARON
Unidade examinadora
M50
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Veracyte
HalioDx
Representantes
Kevin A. Thompson LADAS & PARRY LLP
Classificação técnica
Classes Nice
Classe 5Classe 9Classe 10Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical products for use in vitro testingfor use in the clinical diagnosisprognosismonitoringprediction of response to treatments and on-going evaluationanalysis and study of a cancertumor or equivalent medical condition; chemical preparations for medical and pharmaceutical use for use in vitro testingfor use in the clinical diagnosticprognosismonitoringprediction of response to treatments and on-going evaluationanalysis and study of a cancertumor or equivalent medical condition; biological reagents for medical use for providing information on diagnostics or identification of biological systems; biological reagents for medical use providing information on diagnostics or identification of biological systems; immunological reagents for medical use; biological reagents for medical diagnosis; medical diagnostic kits comprising reagents and assays for testing tissue samples; biological reagents for medical research; biological reagents for medical use; biological reagents for clinical diagnosis
Classe 9
Software for use in the clinical diagnosisprognosismonitoringprediction of response to treatments and on-going evaluationanalysis and study of a cancertumor or equivalent medical condition; application software in the field of biology for use in the clinical diagnosticprognosismonitoringprediction of response to treatments and on-going evaluationanalysis and study of a cancertumor or equivalent medical condition
Classe 10
Medical apparatusinstruments and equipment for medical analysisnamely autostainersscanners; medical apparatus and instruments for providing information on diagnostics or identification of biological systemsmedical testing devices and diagnostic apparatus for detectinganalysing or assessing a cancertumor or equivalent medical condition; medical instruments for cancer cell detection
Classe 42
Scientific research and development; clinical trial servicesintervening in the process of clinical trial services in assessment of biomarkers or signatures; tests in laboratoriesnamely analysis of biological mechanisms of actionsbiomarkers and signatures for research in biology purposes; development of quality control testing methods for others; researchdevelopmenttechnical designtestingconsultancy and analysis services in the field of immunology; research and development of antibodiestherapeutic productsvaccinesimmunotherapy treatments and diagnostic products; research services in the field of genome and immune index analysis; design and development of software in the field of biology
Classe 44
Medical analysis servicesanalysis of tumorcancer or equivalent medical condition; medical assistance; heath care services; medical therapeutic services; medical diagnosticsdiagnostics in the field of medicine; genetic analysis services for medical purposes
Publicações
Histórico de despachos e eventos da marca no USPTO.
39 publicações encontradas
NREP
NEW REPRESENTATIVE AT IB RECEIVED
21/08/2025
C71T
CANCELLED SECTION 71
16/05/2025
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
30/10/2023
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
12/02/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
01/03/2019
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/02/2019
FIMP
FINAL DISPOSITION PROCESSED
07/02/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
30/01/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
30/10/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
14/08/2018
PUBO
PUBLISHED FOR OPPOSITION
14/08/2018
GPNX
NOTIFICATION PROCESSED BY IB
11/08/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
25/07/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
25/07/2018
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
25/07/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/07/2018
RFNP
REFUSAL PROCESSED BY IB
23/06/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
13/06/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/06/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/06/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/05/2018
GNRT
NON-FINAL ACTION E-MAILED
03/05/2018
CNRT
NON-FINAL ACTION WRITTEN
03/05/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
21/02/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
21/02/2018
ALIE
ASSIGNED TO LIE
19/02/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/02/2018
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
31/01/2018
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
31/01/2018
RFNT
REFUSAL PROCESSED BY IB
09/09/2017
MAFR
APPLICATION FILING RECEIPT MAILED
19/08/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
18/08/2017
RFRR
REFUSAL PROCESSED BY MPU
18/08/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
17/08/2017
CNRT
NON-FINAL ACTION WRITTEN
16/08/2017
DOCK
ASSIGNED TO EXAMINER
15/08/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
15/08/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/08/2017
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace HALIOSEEK ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.